A growing number of studies indicate the involvement of autocrine GH and IGF1 in tumor growth promotion, and demonstrate that effective therapeutic options for cancer treatment need to drastically lower serum IGF1, reviewed in (13):. This evidence concerns the gene IGF1 and cancer.